Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kah-Whye Peng

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Chinese Clinical Oncology|May 17, 2018
The emerging role of oncolytic virus therapy against cancerLuke Russell, Kah-Whye Peng
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2017
Oncolytic Virotherapy: A Contest between Apples and OrangesStephen J Russell, Kah-Whye Peng
Trends in Pharmacological Sciences|June 19, 2007
Viruses as anticancer drugsStephen J Russell, Kah-Whye Peng
Current Opinion in Molecular Therapeutics|August 7, 2008
The utility of cells as vehicles for oncolytic virus therapiesStephen J Russell, Kah Whye Peng
Mayo Clinic Proceedings|November 7, 2003
Primer on medical genomics. Part X: Gene therapyStephen J Russell, Kah-Whye Peng
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2025
Cancer viroimmunotherapy platforms based on varicella-zoster virus and cytomegalovirusHaifei Jiang, Kah Whye Peng, Stephen J Russell
Human Gene Therapy|January 13, 2012
Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapyHongtao Li, Kah-Whye Peng, Stephen J Russell
Journal of Virology|October 4, 2013
Characteristics of oncolytic vesicular stomatitis virus displaying tumor-targeting ligandsArun Ammayappan, Kah-Whye Peng, Stephen J Russell
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2010
Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriersChunsheng Liu, Stephen J Russell, Kah-Whye Peng
Nature Biotechnology|July 12, 2012
Oncolytic virotherapyStephen J Russell, Kah-Whye Peng, John C Bell
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Chinese Clinical Oncology|May 17, 2018
The emerging role of oncolytic virus therapy against cancerLuke Russell, Kah-Whye Peng
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2017
Oncolytic Virotherapy: A Contest between Apples and OrangesStephen J Russell, Kah-Whye Peng
Trends in Pharmacological Sciences|June 19, 2007
Viruses as anticancer drugsStephen J Russell, Kah-Whye Peng
Current Opinion in Molecular Therapeutics|August 7, 2008
The utility of cells as vehicles for oncolytic virus therapiesStephen J Russell, Kah Whye Peng
Mayo Clinic Proceedings|November 7, 2003
Primer on medical genomics. Part X: Gene therapyStephen J Russell, Kah-Whye Peng
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2025
Cancer viroimmunotherapy platforms based on varicella-zoster virus and cytomegalovirusHaifei Jiang, Kah Whye Peng, Stephen J Russell
Human Gene Therapy|January 13, 2012
Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapyHongtao Li, Kah-Whye Peng, Stephen J Russell
Journal of Virology|October 4, 2013
Characteristics of oncolytic vesicular stomatitis virus displaying tumor-targeting ligandsArun Ammayappan, Kah-Whye Peng, Stephen J Russell
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2010
Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriersChunsheng Liu, Stephen J Russell, Kah-Whye Peng
Nature Biotechnology|July 12, 2012
Oncolytic virotherapyStephen J Russell, Kah-Whye Peng, John C Bell
Pageof 12